98%
921
2 minutes
20
Development and validation of screening tools for eating disorders is crucial for enhancing early intervention efforts among military-connected populations. The recently released Minnesota Multiphasic Personality Inventory-3 (MMPI-3) includes the novel Eating Concerns (EAT) scale to assess aspects of problematic eating behavior. Our study evaluated the effectiveness of EAT by comparing it to a multidimensional indicator of eating disorder-related pathology. We examined responses from 349 U.S. National Guard veterans and their romantic partners using both the MMPI-3 and the Eating Pathology Symptoms Inventory (EPSI). Participants were 53% men, 47% women, 76% employed, and 97% White. The EAT scale best reflected EPSI domains of binge eating, body dissatisfaction, purging, negative attitudes toward obesity, and restricting. Furthermore, the EAT scale uniquely predicted multiple EPSI scale scores above and beyond other conceptually relevant MMPI-3 scales. Analyses based on gender revealed notable group differences and changes in the strength of associations for EAT and specific EPSI domain scores. Our findings provide support for the incremental and convergent validity of the EAT scale with implications for the increasing use of the MMPI-3 in the U.S. Veterans Affairs health care systems. Overall, EAT appears to effectively identify problematic eating behaviors associated with the item content of the scale (binging, restricting, purging). However, identification of less stereotypic clinically relevant behaviors related to eating or body image (e.g., excessive exercise) may require additional targeted assessment. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1037/ser0000991 | DOI Listing |
Neuro Endocrinol Lett
September 2025
Department of Pediatric Neurology, Cukurova University Faculty of Medicine, Adana, Turkey.
Objective: It is important to raise awareness of the nutritional problems that can be overlooked during the follow-up visits with children who suffer from neuromuscular diseases, as these dietary differences may lead to additional neurological and systemic problems and impair the quality of life of the patient. The aim of this study was to evaluate the nutritional status of children with neuromuscular disorders and to prevent possible complications by recognizing possible nutritional problems in advance.
Methods: Patients who applied to the outpatient clinic at Cukurova University, Faculty of Medicine, Department of Pediatric Neurology beginning in April 2022 with a neuromuscular disorder diagnosis were followed up with and were included in the study.
Eat Disord
September 2025
Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia Pennsylvania, United States of America.
Intelligence Quotient (IQ) scores, typically considered stable throughout life, may be impacted by anorexia nervosa (AN). This study investigated whether IQ scores change following treatment in adolescents with AN ( = 110; age = 14.65 ± 2.
View Article and Find Full Text PDFInt J Eat Disord
September 2025
Department of Emergency Psychiatry and Acute Care, Lapeyronie Hospital, Montpellier, France.
Objective: This study compared overvaluation of weight and shape (OWS), drive for thinness (DT), and their combination (OWS-DT) as alternative severity classifications for anorexia nervosa (AN) to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) severity classification.
Method: 312 AN treatment-seeking outpatients (mean age = 26.8, SD = 10.
Diabetes Obes Metab
September 2025
Eli Lilly and Company, Indianapolis, Indiana, USA.
Aims: To determine whether adults with type 2 diabetes (T2D) treated with retatrutide report greater changes in self-reported appetite, dietary restraint, and disinhibition compared to placebo or dulaglutide and to examine associations with weight change.
Materials And Methods: These pre-specified exploratory analyses examined changes from baseline in Appetite Visual Analogue Scale (VAS) and Eating Inventory (EI) scores after 24 and 36 weeks of once-weekly treatment with placebo, dulaglutide 1.5 mg, or retatrutide 0.
Clin Nutr ESPEN
September 2025
Laboratório de Nutrição e Metabolismo (LANUM), Faculdade de Nutrição, Universidade Federal de Alagoas, Campus AC Simões, Av. Lourival Melo Mota, S/n, Cidade Universitária, Maceió, AL, 57072-900, Brazil. Electronic address:
Background: Obesity and the consumption of ultra-processed foods (UPF) are associated with gut microbiota composition and diversity, which may contribute to alterations in the regulation of hormones involved in satiety, given the gut microbiota's role in regulating host appetite. Therefore, this study aimed to investigate the association of gut microbiota composition and alpha-diversity at the genus-level on postprandial changes in satiety hormones, and appetitive measures in individuals with obesity, given either a meal rich in UPF or a meal without UPF.
Methods: Individuals were randomized to two groups: a) a non-UPF meal and b) a UPF meal.